Artemis Therapeutics, Inc. (ATMS)

Market Cap	145.64M
Revenue (ttm)	n/a
Net Income (ttm)	197,000
Shares Out	112.03M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5
Open	1.4
Previous Close	1.3
Day's Range	1.3 - 1.3
52-Week Range	0.55 - 5
Beta	-1.08
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2022

About ATMS

Artemis Therapeutics Inc., a beauty company, develops and distributes skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with enhanced vitamin C, day cream, night nourishing cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel. It also distributes manuka honey imported from New Zealand. The company was incorporated in 2020 and is based in Ramat Gan, Israel.

• Industry: Pharmaceuticals
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATMS